Harvest Group Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Harvest Group Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26	Closed	-$2K	–	215
2020 Q4	$2K	Hold	26	–	–	﹤0.01%	350
2020 Q3	$3K	Hold	26	–	–	﹤0.01%	297
2020 Q2	$2K	Hold	26	–	–	﹤0.01%	299
2020 Q1	$1K	Sell	26 -10	-28%	-$576	﹤0.01%	371
2019 Q4	$1K	Buy	36 +10	+38%	+$542	﹤0.01%	756
2019 Q3	$1K	Sell	26 -33	-56%	-$1.54K	﹤0.01%	849
2019 Q2	$2K	Buy	59 +33	+127%	+$1.58K	﹤0.01%	526
2019 Q1	$1K	Buy	+26	New	+$1.53K	﹤0.01%	761

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Group Wealth Management's EBS Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Emergent Biosolutions (EBS) in Q1 2021, closing a stake of 26 shares — an estimated $2K sold.

Harvest Group Wealth Management first reported a position in EBS in Q1 2019 and held it in 8 quarters. The position peaked at $3K in Q3 2020. 340 funds tracked by Wall St. Rank hold EBS as of Q1 2021.

Harvest Group Wealth Management reported no remaining Emergent Biosolutions position as of Q1 2021 after selling out during the quarter.
Harvest Group Wealth Management sold 26 Emergent Biosolutions shares in Q1 2021, an estimated $2K.
Harvest Group Wealth Management first reported a position in Emergent Biosolutions in Q1 2019 and held it in 8 quarters.
Harvest Group Wealth Management's Emergent Biosolutions position peaked at $3K in Q3 2020.
340 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.